CN111643472B - 一种盐酸安非他酮缓释片及其制备方法 - Google Patents
一种盐酸安非他酮缓释片及其制备方法 Download PDFInfo
- Publication number
- CN111643472B CN111643472B CN202010651628.3A CN202010651628A CN111643472B CN 111643472 B CN111643472 B CN 111643472B CN 202010651628 A CN202010651628 A CN 202010651628A CN 111643472 B CN111643472 B CN 111643472B
- Authority
- CN
- China
- Prior art keywords
- bupropion hydrochloride
- sustained release
- bupropion
- preparation
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010651628.3A CN111643472B (zh) | 2020-07-08 | 2020-07-08 | 一种盐酸安非他酮缓释片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010651628.3A CN111643472B (zh) | 2020-07-08 | 2020-07-08 | 一种盐酸安非他酮缓释片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111643472A CN111643472A (zh) | 2020-09-11 |
CN111643472B true CN111643472B (zh) | 2021-03-19 |
Family
ID=72347753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010651628.3A Active CN111643472B (zh) | 2020-07-08 | 2020-07-08 | 一种盐酸安非他酮缓释片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111643472B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101843616A (zh) * | 2010-06-04 | 2010-09-29 | 西安万隆制药有限责任公司 | 一种盐酸非索非那定与微晶纤维素组合物及其制备方法 |
CN101869553A (zh) * | 2009-04-24 | 2010-10-27 | 上海安必生制药技术有限公司 | 一种盐酸安非他酮缓释片及其制备方法 |
CN102631350A (zh) * | 2012-03-29 | 2012-08-15 | 南京正科制药有限公司 | 一种富马酸喹硫平与鲁拉西酮的复方制剂 |
-
2020
- 2020-07-08 CN CN202010651628.3A patent/CN111643472B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869553A (zh) * | 2009-04-24 | 2010-10-27 | 上海安必生制药技术有限公司 | 一种盐酸安非他酮缓释片及其制备方法 |
CN101843616A (zh) * | 2010-06-04 | 2010-09-29 | 西安万隆制药有限责任公司 | 一种盐酸非索非那定与微晶纤维素组合物及其制备方法 |
CN102631350A (zh) * | 2012-03-29 | 2012-08-15 | 南京正科制药有限公司 | 一种富马酸喹硫平与鲁拉西酮的复方制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN111643472A (zh) | 2020-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8722087B2 (en) | Titration dosing regimen for controlled release tramadol | |
US6316031B1 (en) | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer | |
Abdelkader et al. | Formulation of controlled-release baclofen matrix tablets: Influence of some hydrophilic polymers on the release rate and in vitro evaluation | |
NO312577B1 (no) | Fremgangsmåte for fremstilling av en stabilisert formulering med regulert frigivelse omfattende et substrat belagt med envandig dispersjon av etylcellulose | |
EP3981399A1 (en) | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor | |
JP2013533303A (ja) | 保存に安定な製剤を製造するための結合剤の使用 | |
US20160346267A1 (en) | Pharmaceutical Composition Comprising Apixaban | |
CN112494437A (zh) | 含羟氯喹类化合物的药物组合物、片剂及其制备方法 | |
CN111643472B (zh) | 一种盐酸安非他酮缓释片及其制备方法 | |
CN112294770A (zh) | 单硝酸异山梨酯复方制剂及其应用和制备方法 | |
CN103565773A (zh) | 一种盐酸普拉格雷的药物组合物 | |
CN111012753A (zh) | 一种提高丙戊酸钠片剂稳定性的方法 | |
CN115590833A (zh) | 高溶出度稳定性的盐酸乐卡地平片组合物及其制备方法 | |
US20090175934A1 (en) | Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same | |
CN114681423B (zh) | 一种盐酸美金刚片及其制备方法 | |
CN110623934A (zh) | 一种盐酸曲美他嗪缓释片及其制备方法 | |
TWI733299B (zh) | 普加巴林的持續-釋放配方 | |
CN117045610B (zh) | 一种溶出高稳定性的盐酸拉贝洛尔组合物及其制备方法 | |
CN108379233B (zh) | 一种甲基多巴组合物、片剂及制备方法 | |
RU2810575C1 (ru) | Фармацевтическая композиция, включающая мемантин и цитиколин, а также лекарственная форма на основе указанной фармацевтической композиции, включающей мемантин и цитиколин, способ ее получения и применение лекарственной формы на основе фармацевтической композиции, включающей мемантин и цитиколин | |
CN111557922B (zh) | 一种盐酸曲美他嗪制剂及其制备方法 | |
CN112569195B (zh) | 一种比拉斯汀组合物及其制备新工艺 | |
TWI655003B (zh) | Medicine composition for release regulation and preparation method thereof | |
CN111228229A (zh) | 一种盐酸索他洛尔片剂及其制备工艺 | |
CN115212178A (zh) | 一种酒石酸美托洛尔制剂组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210624 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Bupropion hydrochloride sustained release tablets and preparation method thereof Effective date of registration: 20211025 Granted publication date: 20210319 Pledgee: Bank of China Limited Weihai Branch Pledgor: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2021980010533 |